Vitamin D receptor: Key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands

Peter W. Jurutka, Leonid Bartik, G Kerr Whitfield, Douglas R. Mathern, Thomas K. Barthel, Miriam Gurevich, Jui-Cheng Hsieh, Magdalena Kaczmarska, Carol A. Haussler, Mark R Haussler

Research output: Contribution to journalArticle

100 Citations (Scopus)

Abstract

The vitamin D hormone, 1,25-dihydroxyvitamin D3 [1,25(OH) 2D3], binds with high affinity to the nuclear vitamin D receptor (VDR), which recruits its retinoid X receptor (RXR) heterodimeric partner to recognize vitamin D responsive elements (VDREs) in target genes. 1,25(OH)2D3 is known primarily as a regulator of calcium, but it also controls phosphate (re)absorption at the intestine and kidney. Fibroblast growth factor 23 (FGF23) is a phosphaturic hormone produced in osteoblasts that, like PTH, lowers serum phosphate by inhibiting renal reabsorption through Npt2a/Npt2c. Real-time PCR and reporter gene transfection assays were used to probe VDR-mediated transcriptional control by 1,25(OH) 2D3. Reporter gene and mammalian two-hybrid transfections, plus competitive receptor binding assays, were used to discover novel VDR ligands. 1,25(OH)2D3 induces FGF23 78-fold in osteoblasts, and because FGF23 in turn represses 1,25(OH)2D3 synthesis, a reciprocal relationship is established, with FGF23 indirectly curtailing 1,25(OH)2D3-mediated intestinal absorption and counterbalancing renal reabsorption of phosphate, thereby reversing hyperphosphatemia and preventing ectopic calcification. Therefore, a 1,25(OH)2D3-FGF23 axis regulating phosphate is comparable in importance to the 1,25(OH)2D3-PTH axis that regulates calcium. 1,25(OH)2D3 also elicits regulation of LRP5, Runx2, PHEX, TRPV6, and Npt2c, all anabolic toward bone, and RANKL, which is catabolic. Regulation of mouse RANKL by 1,25(OH)2D3 supports a cloverleaf model, whereby VDR-RXR heterodimers bound to multiple VDREs are juxtapositioned through chromatin looping to form a supercomplex, potentially allowing simultaneous interactions with multiple co-modulators and chromatin remodeling enzymes. VDR also selectively binds certain ω3/ω6 polyunsaturated fatty acids (PUFAs) with low affinity, leading to transcriptionally active VDR-RXR complexes. Moreover, the turmeric-derived polyphenol, curcumin, activates transcription of a VDRE reporter construct in human colon cancer cells. Activation of VDR by PUFAs and curcumin may elicit unique, 1,25(OH)2D3-independent signaling pathways to orchestrate the bioeffects of these lipids in intestine, bone, skin/hair follicle, and other VDR-containing tissues.

Original languageEnglish (US)
JournalJournal of Bone and Mineral Research
Volume22
Issue numberSUPPL. 2
DOIs
StatePublished - Dec 2007

Fingerprint

Calcitriol Receptors
Minerals
Ligands
Bone and Bones
Retinoid X Receptors
Vitamin D
Phosphates
Curcumin
Osteoblasts
Unsaturated Fatty Acids
Reporter Genes
Intestines
Transfection
Hormones
Calcium
Hyperphosphatemia
Curcuma
Chromatin Assembly and Disassembly
Competitive Binding
Hair Follicle

Keywords

  • Bone mineral homeostasis
  • Curcumin
  • Essential fatty acids
  • Fibroblast growth factor 23
  • RANKL
  • Vitamin D

ASJC Scopus subject areas

  • Surgery

Cite this

Vitamin D receptor : Key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands. / Jurutka, Peter W.; Bartik, Leonid; Whitfield, G Kerr; Mathern, Douglas R.; Barthel, Thomas K.; Gurevich, Miriam; Hsieh, Jui-Cheng; Kaczmarska, Magdalena; Haussler, Carol A.; Haussler, Mark R.

In: Journal of Bone and Mineral Research, Vol. 22, No. SUPPL. 2, 12.2007.

Research output: Contribution to journalArticle

Jurutka, Peter W. ; Bartik, Leonid ; Whitfield, G Kerr ; Mathern, Douglas R. ; Barthel, Thomas K. ; Gurevich, Miriam ; Hsieh, Jui-Cheng ; Kaczmarska, Magdalena ; Haussler, Carol A. ; Haussler, Mark R. / Vitamin D receptor : Key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands. In: Journal of Bone and Mineral Research. 2007 ; Vol. 22, No. SUPPL. 2.
@article{0d31a984ff934e2d8baef18906af256b,
title = "Vitamin D receptor: Key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands",
abstract = "The vitamin D hormone, 1,25-dihydroxyvitamin D3 [1,25(OH) 2D3], binds with high affinity to the nuclear vitamin D receptor (VDR), which recruits its retinoid X receptor (RXR) heterodimeric partner to recognize vitamin D responsive elements (VDREs) in target genes. 1,25(OH)2D3 is known primarily as a regulator of calcium, but it also controls phosphate (re)absorption at the intestine and kidney. Fibroblast growth factor 23 (FGF23) is a phosphaturic hormone produced in osteoblasts that, like PTH, lowers serum phosphate by inhibiting renal reabsorption through Npt2a/Npt2c. Real-time PCR and reporter gene transfection assays were used to probe VDR-mediated transcriptional control by 1,25(OH) 2D3. Reporter gene and mammalian two-hybrid transfections, plus competitive receptor binding assays, were used to discover novel VDR ligands. 1,25(OH)2D3 induces FGF23 78-fold in osteoblasts, and because FGF23 in turn represses 1,25(OH)2D3 synthesis, a reciprocal relationship is established, with FGF23 indirectly curtailing 1,25(OH)2D3-mediated intestinal absorption and counterbalancing renal reabsorption of phosphate, thereby reversing hyperphosphatemia and preventing ectopic calcification. Therefore, a 1,25(OH)2D3-FGF23 axis regulating phosphate is comparable in importance to the 1,25(OH)2D3-PTH axis that regulates calcium. 1,25(OH)2D3 also elicits regulation of LRP5, Runx2, PHEX, TRPV6, and Npt2c, all anabolic toward bone, and RANKL, which is catabolic. Regulation of mouse RANKL by 1,25(OH)2D3 supports a cloverleaf model, whereby VDR-RXR heterodimers bound to multiple VDREs are juxtapositioned through chromatin looping to form a supercomplex, potentially allowing simultaneous interactions with multiple co-modulators and chromatin remodeling enzymes. VDR also selectively binds certain ω3/ω6 polyunsaturated fatty acids (PUFAs) with low affinity, leading to transcriptionally active VDR-RXR complexes. Moreover, the turmeric-derived polyphenol, curcumin, activates transcription of a VDRE reporter construct in human colon cancer cells. Activation of VDR by PUFAs and curcumin may elicit unique, 1,25(OH)2D3-independent signaling pathways to orchestrate the bioeffects of these lipids in intestine, bone, skin/hair follicle, and other VDR-containing tissues.",
keywords = "Bone mineral homeostasis, Curcumin, Essential fatty acids, Fibroblast growth factor 23, RANKL, Vitamin D",
author = "Jurutka, {Peter W.} and Leonid Bartik and Whitfield, {G Kerr} and Mathern, {Douglas R.} and Barthel, {Thomas K.} and Miriam Gurevich and Jui-Cheng Hsieh and Magdalena Kaczmarska and Haussler, {Carol A.} and Haussler, {Mark R}",
year = "2007",
month = "12",
doi = "10.1359/jbmr.07s216",
language = "English (US)",
volume = "22",
journal = "Journal of Bone and Mineral Research",
issn = "0884-0431",
publisher = "Wiley-Blackwell",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Vitamin D receptor

T2 - Key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands

AU - Jurutka, Peter W.

AU - Bartik, Leonid

AU - Whitfield, G Kerr

AU - Mathern, Douglas R.

AU - Barthel, Thomas K.

AU - Gurevich, Miriam

AU - Hsieh, Jui-Cheng

AU - Kaczmarska, Magdalena

AU - Haussler, Carol A.

AU - Haussler, Mark R

PY - 2007/12

Y1 - 2007/12

N2 - The vitamin D hormone, 1,25-dihydroxyvitamin D3 [1,25(OH) 2D3], binds with high affinity to the nuclear vitamin D receptor (VDR), which recruits its retinoid X receptor (RXR) heterodimeric partner to recognize vitamin D responsive elements (VDREs) in target genes. 1,25(OH)2D3 is known primarily as a regulator of calcium, but it also controls phosphate (re)absorption at the intestine and kidney. Fibroblast growth factor 23 (FGF23) is a phosphaturic hormone produced in osteoblasts that, like PTH, lowers serum phosphate by inhibiting renal reabsorption through Npt2a/Npt2c. Real-time PCR and reporter gene transfection assays were used to probe VDR-mediated transcriptional control by 1,25(OH) 2D3. Reporter gene and mammalian two-hybrid transfections, plus competitive receptor binding assays, were used to discover novel VDR ligands. 1,25(OH)2D3 induces FGF23 78-fold in osteoblasts, and because FGF23 in turn represses 1,25(OH)2D3 synthesis, a reciprocal relationship is established, with FGF23 indirectly curtailing 1,25(OH)2D3-mediated intestinal absorption and counterbalancing renal reabsorption of phosphate, thereby reversing hyperphosphatemia and preventing ectopic calcification. Therefore, a 1,25(OH)2D3-FGF23 axis regulating phosphate is comparable in importance to the 1,25(OH)2D3-PTH axis that regulates calcium. 1,25(OH)2D3 also elicits regulation of LRP5, Runx2, PHEX, TRPV6, and Npt2c, all anabolic toward bone, and RANKL, which is catabolic. Regulation of mouse RANKL by 1,25(OH)2D3 supports a cloverleaf model, whereby VDR-RXR heterodimers bound to multiple VDREs are juxtapositioned through chromatin looping to form a supercomplex, potentially allowing simultaneous interactions with multiple co-modulators and chromatin remodeling enzymes. VDR also selectively binds certain ω3/ω6 polyunsaturated fatty acids (PUFAs) with low affinity, leading to transcriptionally active VDR-RXR complexes. Moreover, the turmeric-derived polyphenol, curcumin, activates transcription of a VDRE reporter construct in human colon cancer cells. Activation of VDR by PUFAs and curcumin may elicit unique, 1,25(OH)2D3-independent signaling pathways to orchestrate the bioeffects of these lipids in intestine, bone, skin/hair follicle, and other VDR-containing tissues.

AB - The vitamin D hormone, 1,25-dihydroxyvitamin D3 [1,25(OH) 2D3], binds with high affinity to the nuclear vitamin D receptor (VDR), which recruits its retinoid X receptor (RXR) heterodimeric partner to recognize vitamin D responsive elements (VDREs) in target genes. 1,25(OH)2D3 is known primarily as a regulator of calcium, but it also controls phosphate (re)absorption at the intestine and kidney. Fibroblast growth factor 23 (FGF23) is a phosphaturic hormone produced in osteoblasts that, like PTH, lowers serum phosphate by inhibiting renal reabsorption through Npt2a/Npt2c. Real-time PCR and reporter gene transfection assays were used to probe VDR-mediated transcriptional control by 1,25(OH) 2D3. Reporter gene and mammalian two-hybrid transfections, plus competitive receptor binding assays, were used to discover novel VDR ligands. 1,25(OH)2D3 induces FGF23 78-fold in osteoblasts, and because FGF23 in turn represses 1,25(OH)2D3 synthesis, a reciprocal relationship is established, with FGF23 indirectly curtailing 1,25(OH)2D3-mediated intestinal absorption and counterbalancing renal reabsorption of phosphate, thereby reversing hyperphosphatemia and preventing ectopic calcification. Therefore, a 1,25(OH)2D3-FGF23 axis regulating phosphate is comparable in importance to the 1,25(OH)2D3-PTH axis that regulates calcium. 1,25(OH)2D3 also elicits regulation of LRP5, Runx2, PHEX, TRPV6, and Npt2c, all anabolic toward bone, and RANKL, which is catabolic. Regulation of mouse RANKL by 1,25(OH)2D3 supports a cloverleaf model, whereby VDR-RXR heterodimers bound to multiple VDREs are juxtapositioned through chromatin looping to form a supercomplex, potentially allowing simultaneous interactions with multiple co-modulators and chromatin remodeling enzymes. VDR also selectively binds certain ω3/ω6 polyunsaturated fatty acids (PUFAs) with low affinity, leading to transcriptionally active VDR-RXR complexes. Moreover, the turmeric-derived polyphenol, curcumin, activates transcription of a VDRE reporter construct in human colon cancer cells. Activation of VDR by PUFAs and curcumin may elicit unique, 1,25(OH)2D3-independent signaling pathways to orchestrate the bioeffects of these lipids in intestine, bone, skin/hair follicle, and other VDR-containing tissues.

KW - Bone mineral homeostasis

KW - Curcumin

KW - Essential fatty acids

KW - Fibroblast growth factor 23

KW - RANKL

KW - Vitamin D

UR - http://www.scopus.com/inward/record.url?scp=39749101219&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39749101219&partnerID=8YFLogxK

U2 - 10.1359/jbmr.07s216

DO - 10.1359/jbmr.07s216

M3 - Article

C2 - 18290715

AN - SCOPUS:39749101219

VL - 22

JO - Journal of Bone and Mineral Research

JF - Journal of Bone and Mineral Research

SN - 0884-0431

IS - SUPPL. 2

ER -